| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |